2012年广东省基本药物集中招标采购情况分析

Analysis of Centralized Bidding and Purchasing of Essential Drugs in Guangdong Province in 2012

目的:为进一步规范基本药物集中招标采购工作提供参考。方法:对广东省2012年基本药物集中招标采购中标药物的品规、企业、价格等进行分析,探讨基本药物集中招标采购制度的改进措施。结果:广东省2012年基本药物集中招标共有3697个品规中标。其中,《低价药品目录》品规1323个;中标生产企业947家;有58个目录内药物品种没有中标,其中31个属于国家基本药物目录品种。结论:广东省基本药物中标品种及企业分布相对较合理;基本药物目录不适宜、临床需求量少、限价过低等原因导致部分品规未中标。建议政府采取相应措施完善基本药物集中招标采购制度。

OBJECTIVE：To provide reference for the standardization of centralized bidding and purchasing of essential drugs.METHODS：The bid-winning essential drugs in Guangdong province in 2012 were analyzed statistically in terms of specification,manufacturers and prices,etc.The improvement measures of centralized bidding and purchasing system of essential drugs were investigated.RESULTS：3 697 specifications of essential drugs won the bid during centralized bidding and purchasing of essential drugs in Guangdong province in 2012;there were 1 323 specifications in Low-price List;947 manufacturers won the bid;58 drugs in essential drug list lost the bid,including 31 drugs belonged to National Essential Drug List.CONCLUSION：Variety and enterprise distribution of bid-winning drugs were reasonable in Guangdong province relatively;some specifications lost the bid because of inappropriate essential drug list,low clinical demand,unreasonable low price and so on.It is suggested to take measurements relatively to perfect centralized bidding and purchasing system of essential drugs.